Favorable outcomes of front-line risk-adapted therapy in young patients with diffuse large B-cell lymphoma with clinically or biologically high-risk features
对于具有临床或生物学高危特征的年轻弥漫性大B细胞淋巴瘤患者，一线风险适应性治疗可取得良好疗效。
期刊:Chinese Medical Journal
影响因子:7.3
doi:10.1097/CM9.0000000000002940
Zou, Hesong; Liu, Wei; Wang, Yi; Shan, Dandan; Xie, Ting; Li, Ru; Liu, Huimin; Huang, Wenyang; Fu, Mingwei; Wang, Tingyu; Lyu, Rui; Deng, Shuhui; Sui, Weiwei; Xu, Yan; Yi, Shuhua; An, Gang; Qiu, Lugui; Zou, Dehui
